canthin-6-one has been researched along with Chagas Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| da Costa, WF; de Carvalho, JE; Foglio, MA; Garcia, FP; Leite Silva, CM; Meyer, E; Nakamura, CV; Rodrigues, JH; Ruiz, AL; Sarragiotto, MH; Ueda-Nakamura, T | 1 |
| de Arias, AR; de Bilbao, NV; Ferreira, ME; Fournet, A; Hocquemiller, R; Lagoutte, D; Nakayama, H; Poupon, E; Schinini, A; Serna, E; Soriano-Agatón, F | 1 |
2 other study(ies) available for canthin-6-one and Chagas Disease
| Article | Year |
|---|---|
Synthesis, antitumor, antitrypanosomal and antileishmanial activities of benzo[4,5]canthin-6-ones bearing the N'-(Substituted benzylidene)-carbohydrazide and N-Alkylcarboxamide groups at C-2.
Topics: Antineoplastic Agents; Benzylidene Compounds; Carbolines; Cell Line, Tumor; Chagas Disease; Humans; Indole Alkaloids; Indoles; Inhibitory Concentration 50; Leishmania; Leishmaniasis; Naphthyridines; Neoplasms; Trypanocidal Agents; Trypanosoma cruzi | 2012 |
Effects of canthin-6-one alkaloids from Zanthoxylum chiloperone on Trypanosoma cruzi-infected mice.
Topics: Alkaloids; Animals; Carbolines; Chagas Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Indole Alkaloids; Indoles; Male; Mice; Mice, Inbred BALB C; Naphthyridines; Nitroimidazoles; Survival Rate; Trypanocidal Agents; Trypanosoma cruzi; Zanthoxylum | 2007 |